Type 1 diabetes (T1D) is an autoimmune disorder typically developing within the first 5–6 years of life, beginning with inflammation of the pancreas, progression to autoimmunity and ultimately destruction of insulin-producing beta cells in the pancreas, resulting in dependence on daily exogenous insulin to control blood glucose levels. This evidence concerns the gene INS and type 1 diabetes mellitus.